Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Structural Biology of the S1P1 Receptor.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
Smokers run increased risk of developing anti-natalizumab antibodies.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
Molecular mimicry in the etiology of autoimmune diseases.
Co-Existence of Familial Mediterranean Fever and Multiple Sclerosis in Two Patients.
LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.
Spousal support as experienced by people with multiple sclerosis: a qualitative study.
Evaluation of new immunological targets in neuromyelitis optica.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Patient autonomy in multiple sclerosis - Possible goals and assessment strategies.
Cell-based therapy approaches: the hope for incurable diseases.
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis.
Exercise for Managing the Symptoms of Multiple Sclerosis.
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
Ocular inflammation in neurorheumatic disease.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Pages
« first
‹ previous
…
278
279
280
281
282
283
284
285
286
…
next ›
last »